Back to Results
First PageMeta Content
Health / Non-24-hour sleep-wake disorder / Tasimelteon / Melatonin / Circadian rhythm / Entrainment / Phase response curve / Sleep / Clinical trial / Circadian rhythms / Biology / Physiology


TASIMELTEON ADVISORY COMMITTEE MEETING BRIEFING MATERIALS 14 NOVEMBER 2013
Add to Reading List

Open Document

File Size: 2,64 MB

Share Result on Facebook

City

Bristol / /

Company

ADME AE / UQ-dTSD Vanda Pharmaceuticals Inc. / Tasimelteon Advisory Committee Briefing Materials Vanda Pharmaceuticals Inc. / ITT / Vanda Pharmaceuticals Inc. / /

Event

Product Issues / FDA Phase / Product Recall / /

Facility

Laboratory Values / /

MedicalCondition

Disorder / Blindness / /

Organization

FDA / Food and Drug Administration / /

Person

SAE SAS SCN SD / /

Product

Gamma / study of the Efficacy / ACTH / Plasma Concentration-Time Curve Body Mass Index Bristol-Myers Squibb Benzodiazepine / Cytochrome Drug / Non-24 / N24CRS / /

Technology

Pharmacokinetics / CGI / /

SocialTag